Agneta Heierson
Corporate Officer/Principal en INFANT BACTERIAL THERAPEUTICS AB .
Perfil
Agneta Heierson is currently the Vice President-Clinical Development at Infant Bacterial Therapeutics AB.
She previously worked as the Global VP-Research & Development Supply Chain at AstraZeneca AB.
Cargos activos de Agneta Heierson
Empresas | Cargo | Inicio |
---|---|---|
INFANT BACTERIAL THERAPEUTICS AB | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Agneta Heierson.
Empresas | Cargo | Fin |
---|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
INFANT BACTERIAL THERAPEUTICS AB | Health Technology |
Empresas privadas | 1 |
---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Bolsa de valores
- Insiders
- Agneta Heierson